These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects. Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716 [TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation. Niibe Y; Yamashita H; Sekiguchi K; Takahashi W; Shiraishi K; Okuma K; Terahara A; Kawamori J; Nakagawa K Anticancer Res; 2015 Sep; 35(9):4903-8. PubMed ID: 26254386 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients. Niibe Y; Yamamoto T; Onishi H; Yamashita H; Katsui K; Matsumoto Y; Oh RJ; Aoki M; Shintani T; Yamada K; Kobayashi M; Ozaki M; Manabe Y; Yahara K; Nishikawa A; Kakuhara H; Yamamoto K; Inoue T; Takada YU; Nagata K; Suzuki O; Terahara A; Jingu K Anticancer Res; 2020 Jan; 40(1):393-399. PubMed ID: 31892592 [TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028 [TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy. Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ Acta Oncol; 2019 Jan; 58(1):74-80. PubMed ID: 30280633 [TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer. Kissel M; Martel-Lafay I; Lequesne J; Faivre JC; Le Péchoux C; Stefan D; Barraux V; Loiseau C; Grellard JM; Danhier S; Lerouge D; Chouaid C; Gervais R; Thariat J BMC Cancer; 2019 Dec; 19(1):1237. PubMed ID: 31856742 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study. Mazzola R; Fersino S; Ferrera G; Targher G; Figlia V; Triggiani L; Pasinetti N; Lo Casto A; Ruggieri R; Magrini SM; Alongi F Med Oncol; 2018 Aug; 35(9):121. PubMed ID: 30076479 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study. Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115 [TBL] [Abstract][Full Text] [Related]
10. Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival. Yamamoto T; Niibe Y; Aoki M; Shintani T; Yamada K; Kobayashi M; Yamashita H; Ozaki M; Manabe Y; Onishi H; Yahara K; Nishikawa A; Katsui K; Oh RJ; Terahara A; Jingu K BMC Cancer; 2020 Oct; 20(1):997. PubMed ID: 33054721 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy. Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity. Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292 [TBL] [Abstract][Full Text] [Related]
13. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence. Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944 [TBL] [Abstract][Full Text] [Related]
16. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma. Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330 [TBL] [Abstract][Full Text] [Related]
17. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687 [TBL] [Abstract][Full Text] [Related]
18. Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases. Yamamoto T; Niibe Y; Matsumoto Y; Aoki M; Oh RJ; Ozaki M; Kobayashi M; Manabe Y; Shintani T; Dekura Y; Onishi H; Yamashita H; Jingu K Cancer Med; 2020 Dec; 9(23):8902-8911. PubMed ID: 33022899 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer. Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933 [TBL] [Abstract][Full Text] [Related]
20. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]